Optimal Time for Postpartum Hemoglobin Assessment and Its Correlation With Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Columbia University
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Correlation of maternal hemoglobin to EBL
Study Overview
Brief Summary
This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).
Detailed Description
Postpartum hemorrhage is a leading cause of maternal mortality and morbidity worldwide. Early intervention is dependent on care providers ability to accurately estimate ongoing blood loss. Studies in the past have shown that obstetricians and midwives tend to overestimate blood loss when the lost volumes are small while tend to underestimate by as much as 40 to 50 percent when a large volume of blood is lost.
Multiple studies have shown that routine hemoglobin assessment in postpartum patients after uneventful delivery either vaginal or via cesarean section, is not necessary. This leads to increased cost of care without any added benefit and causes inconvenience to the patients. However knowing how imprecise blood loss estimation can be it is reasonable to screen women for anemia prior to discharge.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •All antepartum patients receiving prenatal care at the Broadway Practice and plan to deliver at Allen Hospital in NYC.
Exclusion Criteria
- •Patients who gave consent to participate in the study but did not deliver at Allen hospital.
Outcomes
Primary Outcomes
Correlation of maternal hemoglobin to EBL
Time Frame: Up to 2 days after delivery
Maternal hemoglobin will be measured to assess correlation to visually estimated blood loss
Correlation of maternal hemoglobin to QBL
Time Frame: Up to 2 days after delivery
Maternal hemoglobin will be measured to assess correlation to quantified blood loss
Change in maternal hemoglobin
Time Frame: Day 1 and Day 2
Maternal hemoglobin will be measured on postpartum day 1 to day 2
Secondary Outcomes
No secondary outcomes reported
Investigators
Rachana Gavara
Assistant Professor of Obstetrics and Gynecology
Columbia University
